CD19-CART in the Treatment of R/R CD19 Positive Non-Hodgkin's Lymphoma
Condition: Non Hodgkin Lymphoma Intervention: Biological: CD19 CAR-T cells infusion Sponsors: PersonGen BioTherapeutics (Suzhou) Co., Ltd.; The First Affiliated Hospital of Zhengzhou University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials